Subscribe to RSS
DOI: 10.1055/s-0032-1318485
One-Pot Synthesis of Pentasubstituted Pyrroles from Propargylic Alcohols, Amines, and Dialkyl Acetylenedicarboxylates; Tandem Amination, Propargylation and Cycloisomerization Catalyzed by Molecular Iodine[ 1 ]
Publication History
Received: 18 January 2013
Accepted after revision: 25 February 2013
Publication Date:
13 March 2013 (online)
Abstract
A multicomponent one-pot synthesis of fully substituted pyrroles has been developed by the tandem reaction of amines, dialkyl acetylenedicarboxylates, and propargylic alcohols using iodine as a catalyst. The reaction was complete in three hours and afforded the products in high yields (75–88%). The method is simple, efficient, cost-effective, and metal-free.
#
Pyrrole derivatives are a class of important heterocyclics representing structural elements of various bioactive natural products such as chlorophyll, bile pigments, heme, and vitamin B12.[2] [3] The pyrrole ring is also the structural unit of different drugs having anticancer,[ 4a ] antitumor,[ 3a ] antibacterial,[ 3b ] and immune suppression activities.[ 3c ] Several pyrrole derivatives are cholesterol lowering agents (atorvastatin or lipitor)[ 4b ] and HIV fusion inhibitors. In addition, they are flexible intermediates for transformation into valuable bioactive heterocyclic systems.[ 5 ] Pyrrole derivatives are also applied for the preparation of semiconducting and fluorescence materials.[ 6 ] Consequently, a wide range of methods have been discovered for the synthesis of pyrroles[ 7 ] using various metal salts (Pd, Ni, Fe, Cu, Zn, Mg, etc.). However, these methods suffer from several drawbacks such as, use of toxic metals, tedious experimental procedure, and unsatisfactory yield. Recently, synthesis of pyrroles applying multi-component reaction (MCR) strategy has attracted much attention of chemists. The MCR strategy combining three or more starting materials in a single synthetic operation provides high atom economy and bond forming efficiency without isolation and purification of any intermediate, which in turn minimize the waste, labor, and cost.[ 8 ] Recently, we reported a simple and efficient metal-free synthesis of tetrasubstituted pyrroles by applying iodine-catalyzed four-component coupling reactions of aldehydes, amines, dialkyl acetylenedicarboxylates, and nitromethane in one pot.[ 9 ] Herein we wish to report a three-component metal-free synthesis of pentasubstituted pyrroles.
In continuation of our work[ 10 ] on the development of useful synthetic methodologies, we have discovered that the three-component coupling of propargylic alcohols, amines, and dialkyl acetylenedicarboxylates in the presence of molecular iodine as a catalyst in toluene afforded the corresponding pentasubstituted pyrroles under reflux condition (Scheme [1]).


Initially, the reaction of secondary propargylic alcohol (derived from the benzaldehyde and phenylacetylene) and aniline was conducted directly with dimethyl acetylenedicarboxylates in the presence of 10 mol% of Cu(OTf)2 as a single catalyst in 1,2-dichloroethane (DCE) under reflux (Scheme [2]). After 12 hours, complete consumption of propargylic alcohol was observed and the corresponding pentasubstituted pyrrole was obtained in 61% yield (Table 1, entry 1). To extend the scope of the amination, propargylation, and cycloisomerization tandem reaction for the synthesis of pyrroles, the present reaction was screened with other different catalysts and solvent systems. When the reaction was performed in toluene in the presence of 5 mol% of AgOAc along with 10 mol% of Cu(OTf)2 the yield increased to 70% (entry 3). By using 10 mol% of the copper-free catalyst InCl3 the reaction furnished the expected pyrrole in 77% yield under similar conditions (entry 4). However, with the catalysts like FeCl3, YbCl3, BiCl3, or AgOTf, the tandem reaction led not to the expected pyrrole but to the intermediate γ-alkynylamine B (Scheme [2], vide infra) (entries 5–8). Further to extend the scope for better catalytic system, the reaction mixture was treated with 10 mol% of molecular iodine in DCE; after refluxing for six hours, the expected pyrrole was obtained in 72% yield (entry 9). To get better yield the mixture was again treated with 5 mol% of AgOAc along with 10 mol% of molecular iodine affording the pyrrole in 83% yield. Use of CuOAc instead of AgOAc did not lead to better result. Finally, when the reaction mixture was treated with 10 mol% of iodine in toluene under reflux for three hours the expected pyrrole was formed in 88% yield. This is the best result in comparison to other catalysts investigated in the present reaction (Table 2).
a Reaction conditions: aniline (0.5 mmol), dimethyl acetylenedicarboxylate (0.56 mmol), 1,3-diphenylprop-2-yn-1-ol (0.5 mmol), solvent (3 mL), and catalyst (10 mol%) under reflux.
b The structure of the product was established from their spectral (IR, 1H and 13C NMR, and ESI-MS) data.
c Isolated yields after purification.
d AgOAc (5 mol%) along with I2 (10 mol%) were used.
With the optimized reaction conditions, a series of pentasubstituted pyrroles were subsequently synthesized from various secondary propargylic alcohols containing both terminal alkyne as well as internal alkyne having aryl and alkyl substituents in excellent yields (Table 2). Both aromatics and heteroaromatics containing electron-donating and -withdrawing groups underwent the conversion smoothly. Secondary propargylic alcohols furnished the corresponding pyrroles in good yields. However, when R2 = alkyl (Table 2, entries 19, 20) the reaction did not yield the required product probably due to less electron density at the carbon atom attached to the alcohol. On the other hand, amines containing both aromatic and aliphatic substituents underwent the conversion smoothly. The pyrroles were efficiently prepared by using dimethyl and diethyl acetylenedicarboxylates. The conversion was completed only in three hours and the products were formed in high yields (75–88%). The structures of the products were established from their spectral (IR, 1H and 13C NMR, and MS) and analytical data.
a Reaction conditions: amine (0.5 mmol), dialkyl acetylenedicarboxylate (0.56 mmol), propargylic alcohol (0.5 mmol), toluene (3 mL), and I2 (10 mol%) under reflux.
b The structures of the products were established from their spectral (IR,1H and 13C NMR, and ESI-MS) data.
c Isolated yields after purification.
d Product characterized by GCMS.
e Reaction carried out for 12 h.
Iodine, used as a catalyst here, is less expensive and easily available. It acts as a Lewis acid in the tandem reaction of amines, dialkyl acetylenedicarboxylates, and propargylic alcohols. The plausible mechanism of the present conversion involves the initial formation of the intermediate, alkenylamine A catalyzed by iodine (Scheme [2]). Subsequent nucleophilic attack of intermediate A to the propargylic alcohol gives the γ-alkynylamine B. Coordination of iodine to the alkyne enhances the electrophilicity of the alkyne and nuclophilic attack of the amino group to the alkyne led to the intermediate C, which undergoes cycloisomerization to furnish the pyrrole derivative (Scheme [2]).


In conclusion, we have developed a simple and efficient iodine-catalyzed method for the synthesis of fully substituted pyrroles directly from amines, dialkyl acetylenedicarboxylates, and propargylic alcohols in excellent yields. High functional-group tolerance, operational simplicity, minimal waste generation (only water was generated as by-product), and use of cheap catalyst are the main advantages of this method.
Silica gel F254 plates were used for TLC; the spots were examined under UV light and then developed by I2 vapor. Column chromatography was performed with silica gel (BDH 100–200 mesh). Solvents were purified according to standard procedures. The spectra were recorded with the following instruments; IR: PerkinElmer RX FT-IR spectrophotometer; NMR: Varian Gemini 200 MHz (1H) and 50 MHz (13C) spectrometer; MS (ESI): VG-Autospec micromass.
#
Pentasubstituted Pyrroles 4; General Procedure
To a stirred solution of respective amine 2 (0.5 mmol), dialkylacetylene dicarboxylate 1 (0.56 mmol), and propargylic alcohol 3 (0.5 mmol) in toluene (3 mL) was added I2 (10 mol%). The reaction mixture was heated slowly to reflux for 3 h. After completion of the reaction as monitored by TLC (hexane–EtOAc, 5:1), the mixture was cooled to r.t. and diluted with EtOAc (10 mL). The EtOAc layer was washed with sat. aq Na2S2O3 (2 × 2 mL), followed by H2O (5 mL) and brine (5 mL). The residue was dried (Na2SO4), concentrated under reduced pressure, and subjected to column chromatography (hexane–EtOAc, 10:1) to afford the corresponding pentasubstituted pyrroles 4 (Table 2).
#
Dimethyl 5-Benzyl-1,4-diphenyl-1H-pyrrole-2,3-dicarboxylate (4a)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4a (185 mg, 88%) as a brownish oil.
IR (neat): 1731, 1692, 1590, 1452 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.41–7.29 (m, 5 H), 7.29–7.21 (m, 4 H), 7.05 (d, J = 7.0 Hz, 2 H), 6.98 (m, 2 H), 6.66–6.59 (m, 2 H), 3.75 (s, 2 H), 3.70 (s, 3 H), 3.61 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 167.0, 160.2, 138.5, 138.0, 135.3, 133.5, 129.7, 129.1, 129.0, 129.9, 128.8, 127.0, 126.1, 123.7, 122.5, 122.0, 114.2, 52.1, 51.8, 30.8.
MS (ESI): m/z = 426 [M + H]+, 448 [M + Na]+.
HRMS: m/z calcd for C27H23NO4 + Na: 448.149; found: 448.151.
Anal. Calcd for C27H23NO4: C, 64.96; H, 4.36; N, 3.79. Found: C, 64.89; H, 4.39; N, 3.82.
#
Dimethyl 5-Benzyl-4-(4-chlorophenyl)-1-phenyl-1H-pyrrole-2,3-dicarboxylate (4b)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4b (190 mg, 83%) as a yellowish oil.
IR (neat): 1731, 1699, 1592, 1451 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.40–7.35 (m, 4 H), 7.23 (d, J = 8.30 Hz, 1 H), 7.12–7.05 (m, 6 H), 6.90 (d, J = 9.06 Hz, 1 H), 6.68–6.63 (m, 2 H), 3.80 (s, 3 H), 3.75 (s, 5 H), 3.65 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.5, 160.0, 138.1, 136.2, 135.5, 134.5, 133.1, 129.5, 129.3, 128.7, 128.3, 128.2, 129.9, 127.3, 126.2, 123.9, 122.2, 122.0, 114.1, 52.1, 51.6, 29.9.
MS (ESI): m/z = 460 [M + H]+, 482 [M + Na]+.
Anal. Calcd for C27H22ClNO4: C, 70.51; H, 4.82; N, 3.05. Found: C, 70.55; H, 4.79; N, 3.09.
#
Dimethyl 5-Benzyl-4-(4-fluorophenyl)-1-phenyl-1H-pyrrole-2,3-dicarboxylate (4c)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4c (188 mg, 85%) as a dark brownish oil.
IR (neat): 1730, 1798, 1601, 1450 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.32 (dd, J = 7.80, 5.50 Hz, 2 H), 7.10–7.05 (m, 6 H), 7.05– 7.01 (t, J = 8.80 Hz, 2 H), 6.90 (d, J = 7.80 Hz, 2 H), 6.66–6.60 (m, 2 H), 3.74 (s, 5 H), 3.64 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.3, 163.5, 160.2, 138.5, 138.3, 135.2, 131.3, 130.0, 129.3, 129.1, 128.2, 128.1, 127.8, 127.6, 126.1, 115.3, 115.0, 52.1, 51.8, 30.4.
MS (ESI): m/z = 444 [M + H] +, 466 [M + Na]+.
Anal. Calcd C27H22FNO4: C, 73.13; H, 5.00; N, 3.16. Found: C, 73.21; H, 4.96; N, 3.21.
#
Dimethyl 5-Benzyl-4-(4-fluorophenyl)-1-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4d)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4d (176 mg, 78%) as a brownish oil.
IR (neat): 1739, 1695, 1605, 1451 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.33 (dd, J = 7.70, 5.52 Hz, 2 H), 7.11–7.06 (m, 5 H), 7.05–7.01 (t, J = 8.80 Hz, 2 H), 6.90 (d, J = 7.70 Hz, 2 H), 6.68–6.63 (m, 2 H), 3.75 (s, 5 H), 3.65 (s, 3 H), 2.36 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.4, 162.2 (d, J = 285.96 Hz), 160.0, 138.6, 138.3, 135.3, 131.3, 130.0, 129.5, 129.1, 128.2, 128.0, 127.9, 127.6, 126.1, 115.3, 115.0, 52.0, 51.7, 29.9, 21.1.
MS (ESI): m/z = 458 [M + H]+, 480 [M + Na]+.
Anal. Calcd for C28H24FNO4: C, 73.51; H, 5.29; N, 3.06. Found: C, 73.66; H, 5.22; N, 2.11.
#
Dimethyl 5-Benzyl-4-(4-fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrrole-2,3-dicarboxylate (4e)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 12:1) to give 4e (191 mg, 81%) as a light yellowish oil.
IR (neat): 1735, 1709, 1602, 1463 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.37–7.31 (m, 3 H), 7.11–7.07 (m, 2 H), 7.03 (t, J = 8.80 Hz, 2 H), 6.92 (d, J = 8.83 Hz, 2 H), 6.78 (d, J = 8.80 Hz, 2 H), 6.69–6.65 (m, 2 H), 3.80 (s, 3 H), 3.75 (s, 5 H), 3.65 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.2, 163.5, 160.3, 159.5, 138.4, 135.4, 131.4, 131.2, 130.1, 129.5, 128.9, 128.1, 127.9, 129.1, 124.4, 123.9, 119.0, 115.3, 115.08, 114.0, 113.6, 55.3, 52.1, 51.7, 29.6.
MS (ESI): m/z = 474 [M + H]+, 496 [M + Na]+.
Anal. Calcd for C28H24FNO4: C, 71.03; H, 5.11; N, 2.96. Found: C, 71.13; H, 5.07; N, 2.99.
#
Dimethyl 5-Benzyl-4-(4-chlorophenyl)-1-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4f)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 9:1) to give 4f (186 mg, 80%) as a yellowish oil.
IR (neat): 1731, 1591, 1499, 1452 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.32 (d, J = 7.0, 4.0 Hz, 4 H), 7.13–7.08 (m, 5 H), 6.9 (d, J = 7.0 Hz, 2 H), 6.70–6.65 (m, 2 H), 3.78 (s, 5 H), 3.65 (s, 3 H), 2.48 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.5, 160.5, 139.0, 138.5, 135.3, 135.0, 133.2, 132.3, 131.1, 129.4, 128.9, 128.7, 128.5, 126.2, 123.3, 122.5, 121.4, 52.0, 51.8, 30.0, 21.1.
MS (ESI): m/z = 474 [M + H]+, 496 [M + Na]+.
Anal. Calcd for C28H24ClNO4: C, 70.96; H, 5.10; N, 2.96. Found: C, 70.99; H, 5.01; N, 2.83.
#
Dimethyl 5-Benzyl-4-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrrole-2,3-dicarboxylate (4g)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 15:1) to give 4g (198 mg, 82%) as a yellowish oil.
IR (neat): 1729, 1590, 1496, 1447 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.33–7.29 (m, 4 H), 7.13–7.08 (m, 3 H), 6.91 (d, J = 9.0 Hz, 2 H), 6.77 (d, J = 8.30 Hz, 2 H), 6.66 (m, 2 H), 3.81 (s, 2 H), 3.76 (s, 3 H), 3.64 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 167.2, 159.5, 136.4, 135.5, 133.6, 131.0, 130.1, 129.9, 128.5, 128.4, 128.0, 127.9, 127.8, 126.5, 126.1, 121.4, 113.6, 55.5, 52.1, 51.6, 30.5.
MS (ESI): m/z = 490 [M + H]+, 513 [M + Na]+.
Anal. Calcd for C28H24ClNO5: C, 68.64; H, 4.94; N, 2.86. Found: C, 68.71; H, 4.89; N, 2.89.
#
Dimethyl 5-Benzyl-4-(4-methoxyphenyl)-1-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4h)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 8:1) to give 4h (153 mg, 77%) as a brownish oil.
IR (neat): 1724, 1592, 1497, 1446 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.30–7.28 (m, 4 H), 7.10–7.07 (m, 3 H), 6.88 (d, J = 8.8 Hz, 2 H), 6.71 (d, J = 8.3 Hz, 2 H), 6.61–6.65 (m, 2 H), 3.79 (s, 2 H), 3.73 (s, 3 H), 3.61 (s, 3 H), 2.47 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.7, 160.3, 138.6, 136.7, 135.7, 130.5, 130.3, 129.3, 129.0, 128.9, 128.0, 125.9, 123.3, 122.0, 113.5, 55.2, 52.1, 51.6, 30.2, 21.1.
MS (ESI): m/z = 470 [M + H]+, 492 [M + Na]+.
Anal. Calcd for C29H27NO5: C, 74.18; H, 5.80; N, 2.98. Found: C, 74.22; H, 5.77; N, 3.01.
#
Dimethyl 5-Benzyl-1,4-di-p-tolyl-1H-pyrrole-2,3-dicarboxylate(4i)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 8:1) to give 4i (165 mg, 75%) as a colorless oil.
IR (neat): 1732, 1598, 1501, 1450 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.41–7.20 (m, 6 H), 7.08–7.01 (m, 3 H), 6.91–6.82 (m, 2 H), 6.69–6.64 (m, 2 H), 3.77 (s, 2 H), 3.70 (s, 3 H), 3.62 (s, 3 H), 2.36 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 167.2, 160.7, 138.7, 136.8, 135.9, 130.6, 130.4, 128.8, 128.5, 128.2, 127.9, 125.6, 123.3, 122.0, 52.0, 51.5, 30.4, 21.1, 21.1.
MS (ESI): m/z = 454 [M + H]+, 475 [M + Na]+.
Anal. Calcd for C29H27NO4: C, 76.80; H, 6.00; N, 3.09. Found: C, 76.89; H, 5.99; N, 3.11.
#
Dimethyl 5-Benzyl-1-(4-methoxyphenyl)-4-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate(4j)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 15:1) to give 4j (187 mg, 82%) as a yellowish oil.
IR (neat): 1724, 1592, 1497, 1446 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.31–7.27 (m, 4 H), 7.10–7.06 (m, 3 H), 6.88 (d, J = 8.8 Hz, 2 H), 6.71 (d, J = 8.3 Hz, 2 H), 6.61–6.65 (m, 2 H), 3.79 (s, 2 H), 3.73 (s, 3 H), 3.61 (s, 3 H), 2.47 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.7, 160.3, 138.6, 136.7, 135.7, 130.5, 130.3, 129.3, 129.0, 128.9, 128.0, 125.9, 123.3, 122.0, 113.5, 55.2, 52.1, 51.6, 30.5, 21.1.
MS (ESI): m/z = 470 [M + H]+, 492 [M + Na]+.
Anal. Calcd for C29H27NO5: C, 74.18; H, 5.80; N, 2.98. Found: C, 74.22; H, 5.77; N, 3.01.
#
Dimethyl 5-Benzyl-4-phenyl-1-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4k)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 8:1) to give 4k (175 mg, 85%) as a brownish oil.
IR (neat): 1737, 1624, 1530, 1453 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.40–7.21 (m, 6 H), 7.09–7.01 (m, 3 H), 6.92–6.82 (m, 2 H), 6.70–6.62 (m, 2 H), 3.77 (s, 2 H), 3.70 (s, 3 H), 3.61 (s, 3 H), 2.36 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.5, 160.2, 138.4, 137.9, 131.6, 129.5, 129.1, 128.6, 128.4, 128.3, 128.22, 128.1, 128.0, 127.9, 127.8, 127.6, 127.0, 125.9, 30.5, 21.1.
MS (ESI): m/z = 440 [M + H]+, 462 [M + Na]+.
Anal. Calcd C28H25NO4: C, 76.52; H, 5.73; N, 3.19. Found: C, 76.55; H, 5.69; N, 3.21.
#
Dimethyl 5-Benzyl-1-(4-chlorophenyl)-4-phenyl-1H-pyrrole-2,3-dicarboxylate(4l)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4l (193 mg, 86%) as a colorless oil.
IR (neat): 1728, 1612, 1522, 1443, 1254 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.40–7.35 (m, 4 H), 7.23 (d, J = 8.30 Hz, 1 H), 7.12–7.05 (m, 6 H), 6.90 (d, J = 9.06 Hz, 1 H), 6.68–6.63 (m, 2 H), 3.80 (s, 3 H), 3.75 (s, 5 H), 3.65 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.5, 160.0, 138.1, 136.9, 135.5, 134.5, 133.1, 129.4, 129.2, 128.6, 128.3, 128.1, 129.9, 127.2, 126.2, 123.8, 122.7, 116.1, 52.4, 51.6, 29.5.
MS (ESI): m/z = 460 [M + H]+, 482 [M + Na]+.
Anal. Calcd for C27H22ClNO4: C, 70.51; H, 4.82; N, 3.05. Found: C, 70.66; H, 4.76; N, 3.11.
#
Dimethyl 5-Benzyl-1-(4-fluorophenyl)-4-phenyl-1H-pyrrole-2,3-dicarboxylate (4m)
Following the general procedure the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4m (180 mg, 82%) as a dark brownish oil.
IR (neat): 1725, 1582, 1490, 1438 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.43–7.28 (m, 5 H), 7.11–7.07 (m, 3 H), 6.94 (d, J = 6.0 Hz, 4 H), 6.68–6.64 (m, 2 H), 3.79 (s, 2 H), 3.76 (s, 3 H), 3.64 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 166.6, 162.2 (d, J = 285.96 Hz), 160.0, 138.1, 135.6, 133.6, 133.2, 129.7, 128.9, 128.8, 129.6, 129.6, 128.3, 128.1, 127.8, 127.2, 126.1, 115.5, 115.2, 52.1, 51.6, 30.5.
MS (ESI): m/z = 444 [M + H]+, 466 [M + Na]+.
Anal. Calcd for C27H22FNO4: C, 73.13; H, 5.00; N, 3.16. Found: C, 73.19; H, 5.18; N, 3.21.
#
Dimethyl 1,5-Dibenzyl-4-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4n)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4n (195 mg, 87%) as a colorless oil.
IR (neat): 1740, 1630, 1604, 1441 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.31–7.18 (m, 8 H), 7.12 (d, J = 8.22 Hz, 2 H), 7.00 (d, J = 7.40 Hz, 2 H), 6.91 (d, J = 8.22 Hz, 2 H), 5.35 (s, 2 H), 3.87 (s, 2 H), 3.76 (s, 6 H), 2.33 (s, 3 H).
13C NMR (50 MHz, CDCl3): δ = 167.0, 160.7, 138.0, 137.3, 136.7, 134.4, 130.3, 129.2, 129.0, 128.7, 128.6, 127.6, 127.1, 126.5, 125.7, 124.1, 122.9, 120.5, 52.1, 51.6, 48.7, 30.2, 21.1.
MS (ESI): m/z = 454 [M + H]+, 476 [M + Na]+.
Anal. Calcd for C29H27NO4: C, 76.80; H, 6.00; N, 3.09. Found: C, 76.85; H, 5.96; N, 3.11.
#
Dimethyl 5-Heptyl-1,4-diphenyl-1H-pyrrole-2,3-dicarboxylate (4o)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 9:1) to give 4o (175 mg, 82%) as a colorless oil.
IR (neat): 1717, 1565, 1491, 1449, 1296 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.52–7.42 (m, 4 H), 7.40–7.22 (m, 6 H), 3.73 (s, 3 H), 3.63 (s, 3 H), 2.42–2.30 (m, 2 H), 1.18–1.03 (m, 3 H), 1.01–0.83 (m, 5 H), 0.79 (t, J = 6.6 Hz, 3 H).
13C NMR (200 MHz, CDCl3): δ = 166.8, 160.2, 137.9, 133.8, 129.1, 129.5, 128.1, 128.7, 128.0, 126.9, 122.6, 122.2, 120.6, 111.4, 52.1, 51.4, 31.2, 29.5, 29.0, 28.7, 28.2, 24.3, 22.4, 13.9.
MS (ESI): m/z = 434 [M + H]+, 456 [M + Na]+.
Anal. Calcd for C27H31NO4: C, 74.80; H, 7.21; N, 3.23. Found: C, 74.85; H, 7.16; N, 3.27.
#
Dimethyl 5-Heptyl-1-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,3-dicarboxylate (4p)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 15:1) to give 4p (197 mg, 86%) as a yellowish oil.
IR (neat): 1732, 1628, 1531, 1450 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.40–7.29 (m, 5 H), 7.21 (d, J = 9.06 Hz, 2 H), 6.98 (d, J = 8.30 Hz, 2 H), 3.87 (s, 3 H), 3.73 (s, 3 H), 3.65 (s, 3 H), 2.37 (t, J = 8.30 Hz, 2 H), 1.22–1.07 (m, 3 H), 1.05–0.89 (m, 5 H), 0.79 (t, J = 7.55 Hz, 3 H).
13C NMR (200 MHz, CDCl3): δ = 166.8, 160.3, 159.9, 138.3, 133.9, 130.6, 129.5, 129.0, 128.5, 128.1, 126.8, 122.4, 122.1, 121.4, 113.8, 55.3, 52.0, 51.5, 31.3, 29.6, 29.1, 28.8, 28.2, 24.3, 22.4, 13.9.
MS (ESI): m/z = 464 [M + H]+, 476 [M + Na]+.
Anal. Calcd for C28H33NO5: C, 72.55; H, 7.18; N, 3.02. Found: C, 72.59; H, 7.11; N, 3.07.
#
Dimethyl 5-Heptyl-4-phenyl-1-(p-tolyl)-1H-pyrrole-2,3-dicarboxylate (4q)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4q (174 mg, 79%) as a brownish oil.
IR (neat): 1725, 1621, 1527, 1442 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.40–7.31 (m, 5 H), 7.30–7.22 (m, 2 H), 7.17 (d, J = 8.30 Hz, 2 H), 3.73 (s, 3 H), 3.64 (s, 3 H), 2.43 (s, 3 H), 2.37 (t, J = 7.55 Hz, 2 H), 1.22–1.05 (m, 3 H), 1.03–0.89 (m, 5 H), 0.79 (t, J = 6.79 Hz, 3 H).
13C NMR (50 MHz, CDCl3): δ = 167.8, 160.3, 138.6, 138.0, 135.4, 134.0, 129.5, 129.4, 128.9, 128.1, 127.7, 126.9, 122.5, 52.1, 51.5, 31.3, 29.6, 29.1, 28.7, 28.2, 24.3, 22.3, 22.4, 21.2, 13.9.
MS (ESI): m/z = 448 [M + H]+, 470 [M + Na]+.
Anal. Calcd for C28H33NO4: C, 75.14; H, 7.43; N, 3.13. Found: C, 75.19; H, 7.34; N, 3.21.
#
Diethyl 5-Benzyl-1-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,3-dicarboxylate (4r)
Following the general procedure, the crude residue was subjected to column chromatography (hexane–EtOAc, 10:1) to give 4r (179 mg, 76%) as a yellowish oil.
IR (neat): 1728, 1612, 1522, 1443 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.44–7.27 (m, 5 H), 7.10–7.03 (m, 3 H), 6.91 (d, J = 8.83 Hz, 2 H), 6.77 (d, J = 8.83 Hz, 2 H), 6.70–6.64 (m, 2 H), 4.21 (q, J = 7.75 Hz, 2 H), 4.09 (q, J = 7.75 Hz, 2 H), 3.80 (s, 3 H), 3.78 (s, 2 H), 1.17 (t, J = 7.72 Hz, 3 H), 1.12 (t, J = 7.72 Hz, 3 H).
13C NMR (50 MHz, CDCl3): δ = 164.5, 159.4, 138.6, 135.5, 133.3, 132.0, 131.6, 130.5, 129.6, 129.0, 128.2, 128.0, 127.5, 127.8, 127.3, 127.0, 126.0, 113.6, 63.0, 61.0, 60.4, 55.3, 29.6, 14.1, 14.0.
MS (ESI): m/z = 484 [M + H]+, 503 [M + Na]+.
Anal. Calcd for C30H29NO5: C, 74.52; H, 6.04; N, 2.90. Found: C, 74.56; H, 6.01; N, 2.95.
#
#
Acknowledgment
The authors thank CSIR, New Delhi for financial assistance.
Supporting Information
- for this article is available online at http://www.thieme-connect.com.accesdistant.sorbonne-universite.fr/ejournals/toc/synthesis.
- Supporting Information
-
References
- 1 Part 234 in the series Studies on Novel Synthetic Methodologies.
- 2a O’Hagan D. Nat. Prod. Rep. 2000; 17: 435
- 2b Walsh CT, Gameau-Tsodikova S, Howard-Jones AR. Nat. Prod. Rep. 2006; 23: 517
- 2c Reisser M, Maas G. J. Org. Chem. 2008; 69: 4913
- 3a Denny WA, Rewcastle GW, Baguley BC. J. Med. Chem. 1990; 33: 814
- 3b Daidone G, Maggis B, Schillari D. Pharmazie 1990; 45: 441
- 3c Davis FA, Bowen KA, Xu H, Velvadapu V. Tetrahedron 2008; 64: 4174
- 4a Estévez V, Villacampa M, Menéndez JC. Chem. Soc. Rev. 2010; 39: 4402
- 4b Steven EN, Stephen JN, Ilke SD, Peter L, Joel SR. JAMA, J. Am. Med. Assoc. 2006; 295: 1556
- 5a Boger DL, Boyce CW, Labrilli MA, Sehon CA, Jin Q. J. Am. Chem. Soc. 1999; 121: 54
- 5b Abid M, Landge SM, Torok B. Org. Prep. Proced. Int. 2006; 38: 495
- 6a Ramanavicius A, Ramanaviciene A, Malinauskas A. Electrochem. Acta 2006; 51: 6025
- 6b Pu S, Liu G, Shen L, Xu J. Org. Lett. 2007; 9: 2139
- 7a Shiner CM, Taner TD. Tetrahedron 2005; 61: 11628
- 7b Minetto G, Raveglia LF, Sega A, Taddei M. Eur. J. Org. Chem. 2005; 34: 5277
- 7c Larionov OV, de Meijire A. Angew. Chem. Int. Ed. 2005; 44: 5664
- 7d Istrate FM, Gagosz F. Org. Lett. 2007; 9: 318
- 7e Hwang SJ, Cho SH, Chang S. J. Am. Chem. Soc. 2008; 130: 16158
- 7f La YD, Arndtsen BA. Angew. Chem. Int. Ed. 2008; 47: 5430
- 7g Plaskon AS, Ryabukhin SV, Volochnyuk DM, Shivanyuk AN, Tolmachev AA. Tetrahedron 2008; 64: 5933
- 7h Brichacek M, Njardarson JT. Org. Biomol. Chem. 2009; 7: 1760
- 7i Lu Y, Fu X, Chen H, Du X, Jia X, Liu Y. Adv. Synth. Catal. 2009; 351: 129
- 7j Wang J-Y, Wang X-P, Yu Z-S, Yu W. Adv. Synth. Catal. 2009; 351: 2063
- 8a Maity S, Biswas S, Jana U. J. Org. Chem. 2010; 75: 1674
- 8b Dieter RK, Yu H. Org. Lett. 2001; 3: 3855
- 8c Grigg R, Savic V. Chem. Commun. 2000; 873
- 8d Gabriele B, Salerno G, Fazio A. J. Org. Chem. 2003; 68: 7853
- 9 Das B, Bhunia N, Lingaiah M. Synthesis 2011; 347
- 10a Das B, Ramu R, Reddy MR, Mahender G. Synthesis 2005; 250
- 10b Das B, Krishnaiah M, Venkateswarlu K. Tetrahedron Lett. 2006; 47: 4457
- 10c Das B, Damodar K, Bhunia N. J. Org. Chem. 2009; 74: 5607
- 10d Das B, Reddy GC, Balasubramanyam P, Veeranjaneyulu B. Synthesis 2010; 1625
- 10e Reddy GC, Balasubramanyam P, Salvanna N, Das B. Eur. J. Org. Chem. 2012; 471
- 10f Das B, Reddy GC, Balasubramanyam P, Salvanna N. Tetrahedron 2012; 68: 300
Some recent examples:
-
References
- 1 Part 234 in the series Studies on Novel Synthetic Methodologies.
- 2a O’Hagan D. Nat. Prod. Rep. 2000; 17: 435
- 2b Walsh CT, Gameau-Tsodikova S, Howard-Jones AR. Nat. Prod. Rep. 2006; 23: 517
- 2c Reisser M, Maas G. J. Org. Chem. 2008; 69: 4913
- 3a Denny WA, Rewcastle GW, Baguley BC. J. Med. Chem. 1990; 33: 814
- 3b Daidone G, Maggis B, Schillari D. Pharmazie 1990; 45: 441
- 3c Davis FA, Bowen KA, Xu H, Velvadapu V. Tetrahedron 2008; 64: 4174
- 4a Estévez V, Villacampa M, Menéndez JC. Chem. Soc. Rev. 2010; 39: 4402
- 4b Steven EN, Stephen JN, Ilke SD, Peter L, Joel SR. JAMA, J. Am. Med. Assoc. 2006; 295: 1556
- 5a Boger DL, Boyce CW, Labrilli MA, Sehon CA, Jin Q. J. Am. Chem. Soc. 1999; 121: 54
- 5b Abid M, Landge SM, Torok B. Org. Prep. Proced. Int. 2006; 38: 495
- 6a Ramanavicius A, Ramanaviciene A, Malinauskas A. Electrochem. Acta 2006; 51: 6025
- 6b Pu S, Liu G, Shen L, Xu J. Org. Lett. 2007; 9: 2139
- 7a Shiner CM, Taner TD. Tetrahedron 2005; 61: 11628
- 7b Minetto G, Raveglia LF, Sega A, Taddei M. Eur. J. Org. Chem. 2005; 34: 5277
- 7c Larionov OV, de Meijire A. Angew. Chem. Int. Ed. 2005; 44: 5664
- 7d Istrate FM, Gagosz F. Org. Lett. 2007; 9: 318
- 7e Hwang SJ, Cho SH, Chang S. J. Am. Chem. Soc. 2008; 130: 16158
- 7f La YD, Arndtsen BA. Angew. Chem. Int. Ed. 2008; 47: 5430
- 7g Plaskon AS, Ryabukhin SV, Volochnyuk DM, Shivanyuk AN, Tolmachev AA. Tetrahedron 2008; 64: 5933
- 7h Brichacek M, Njardarson JT. Org. Biomol. Chem. 2009; 7: 1760
- 7i Lu Y, Fu X, Chen H, Du X, Jia X, Liu Y. Adv. Synth. Catal. 2009; 351: 129
- 7j Wang J-Y, Wang X-P, Yu Z-S, Yu W. Adv. Synth. Catal. 2009; 351: 2063
- 8a Maity S, Biswas S, Jana U. J. Org. Chem. 2010; 75: 1674
- 8b Dieter RK, Yu H. Org. Lett. 2001; 3: 3855
- 8c Grigg R, Savic V. Chem. Commun. 2000; 873
- 8d Gabriele B, Salerno G, Fazio A. J. Org. Chem. 2003; 68: 7853
- 9 Das B, Bhunia N, Lingaiah M. Synthesis 2011; 347
- 10a Das B, Ramu R, Reddy MR, Mahender G. Synthesis 2005; 250
- 10b Das B, Krishnaiah M, Venkateswarlu K. Tetrahedron Lett. 2006; 47: 4457
- 10c Das B, Damodar K, Bhunia N. J. Org. Chem. 2009; 74: 5607
- 10d Das B, Reddy GC, Balasubramanyam P, Veeranjaneyulu B. Synthesis 2010; 1625
- 10e Reddy GC, Balasubramanyam P, Salvanna N, Das B. Eur. J. Org. Chem. 2012; 471
- 10f Das B, Reddy GC, Balasubramanyam P, Salvanna N. Tetrahedron 2012; 68: 300
Some recent examples:





